Skip to content
OpenCapital
Get started

Cumberland Pharmaceuticals CPIX Kristalose — Revenue

Other product segments

Sancuso
$2.93M+29.8%
Vibativ
$2.12M-29.4%
Talicia
$1.92M—
Caldolor
$896.71K-34.7%
Other revenue
$168.85K-94.6%
Acetadote
$66.67K+65.8%

Similar metrics at other companies

Amgen logo
AMGNKRYSTEXXA — Total revenues
$255M+8.1%
SLD
SLDPKR — Revenue
$1.51M-30.9%
Xperi logo
XPERKR — Revenue
$4.89M-61.7%
Weyerhaeuser logo
WYKR — Revenue
$5.25M-12.5%
Allegro MicroSystems, Inc. logo
ALGMKR — Revenue
$20M+20.4%
Rambus logo
RMBSKR — Revenue (Gross)
$86.51M+27.2%

Other financials

Income statement

See full
Revenue$9.1M-22.0%
Gross profit$7.2M-30.0%
Operating income-$3.1M-342%
Net income-$3.3M-362%
EPS (diluted)-$0.22-375%

Balance sheet

See full
Cash & equivalents$11.0M-27.1%
Total debt$4.8M-7.1%
Total equity$21.6M-24.5%
Total assets$71.0M+1.5%

Cash flow

See full
Operating cash flow$387.0K-90.1%
CapEx--100%
Free cash flow$387.0K-89.9%

Valuation

See full
Market cap$97.09M+142%
Enterprise value$90.91M+212%
P/S2.3×+1.4×

Profitability

See full
Gross margin82.9%-1.4pp
Operating margin-17.2%-125pp
Net margin-17.6%-103pp
FCF margin3.3%—

Returns & leverage

See full
Return on equity-29.4%-86.3pp
Debt / equity0.2×0.0×
Current ratio1×-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's kristalose — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cumberland Pharmaceuticals's kristalose — revenue?
Cumberland Pharmaceuticals (CPIX) reported kristalose — revenue of $981.48K in Q1 2026.
How has Cumberland Pharmaceuticals's kristalose — revenue changed year-over-year?
Cumberland Pharmaceuticals's kristalose — revenue decreased by 71.8% year-over-year, from $3.48M to $981.48K.
What is the long-term trend for Cumberland Pharmaceuticals's kristalose — revenue?
Over 3 years (2022 to 2025), Cumberland Pharmaceuticals's kristalose — revenue has grown at a -11.5% compound annual growth rate (CAGR), from $15.21M to $10.54M.
What does kristalose — revenue mean?
This metric represents the total gross sales generated from the Kristalose product line before any deductions for returns, allowances, or rebates. It serves as a primary indicator of the product's market demand and top-line contribution to the company's specialty pharmaceutical portfolio.